Pharmaceuticals / services Hotline:86-10-67887855
About

About Us

Dedicated to be an exquisite specialized pharmaceutical research company

Beijing Wista Pharma Co., Ltd, founded in 2009, is located in Beijing Economic-Technological Development Area, committed to independent research and sub-contract production for chemical innovative drugs and high-end generic drugs.
Our laboratory area is more than 2000 square meters, which has passed the environmental assessment, fire protection and safety assessment in Beijing, is equipped with a series of precise instruments, like, high performance liquid chromatograph, gas chromatograph, ion chromatography, dissolution tester (manual, automatic), ultraviolet spectrophotometer, atomic absorption, ICP-MS, HPLC-MS, GC-MS, automatic amino acid analyzer (Germany), high-speed tablet press, wet & dry granulator machine, multidimensional mixer, boiling granulator & coating dryer, coating machine, freeze dryer , homogenizer, filling machine, osmotic pressure tester, Particle measuring systems, laser particle size analyzer, powder tester, etc...

MORE
NEWS

News

  • Company News
  • |
  • Industry News
2020-04-23

Our new formulation L-Ornithine-L-Aspartate Infusion for injection has been approved

Our new formulation L-Ornithine-L-Aspartate Infusion for injection( 5gm/10ml ) has been approved by China SFDA on 23th April 2020.

2018-05-01

CPHI China 2018

Welcome your visit us during Cphi Shanghai Booth No.: W4 F88@ Shanghai New Intl Expo Centre (SNIEC), China. June 20~22, 2018.

2017-11-01

CPHI India 2017

Welcome your visit us during COHI Mumbai 2017 Booth No.: CB30A (in CCCMHPIE Pavilion), BKC. Event date: 27th Nov. ~ 29th Nov. 2017

More
2021-07-21

Center for Drug Evaluation of NMPA Announced on Issuing the Administrative easures for Communication of Drug R&D and

Center for Drug Evaluation of NMPA Announced on Issuing the Administrative easures for Communication of Drug R&D and Technical Review

2021-07-13

NMPA Announcement on Issues Pertaining to Online Application for Drug Registration Affairs

NMPA Announcement on Issues Pertaining to Online Application for Drug Registration Affairs

More